Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Receives Average Recommendation of “Hold” from Analysts

Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) have been assigned an average recommendation of “Hold” from the ten ratings firms that are covering the company, MarketBeat.com reports. Six research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $10.1875.

Several brokerages have recently commented on AVAH. Zacks Research cut shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 20th. BMO Capital Markets started coverage on shares of Aveanna Healthcare in a research note on Thursday, November 13th. They issued an “outperform” rating and a $11.00 price target for the company. Barclays raised Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $5.50 to $9.50 in a research report on Tuesday, August 19th. UBS Group boosted their price objective on Aveanna Healthcare from $9.00 to $9.50 and gave the stock a “neutral” rating in a research report on Friday, November 7th. Finally, Raymond James Financial raised shares of Aveanna Healthcare from a “market perform” rating to an “outperform” rating and set a $9.00 target price on the stock in a report on Monday, August 11th.

Aveanna Healthcare Price Performance

Shares of Aveanna Healthcare stock opened at $9.32 on Friday. The stock has a market capitalization of $1.95 billion, a P/E ratio of 25.88 and a beta of 2.04. The business has a 50 day simple moving average of $9.03 and a two-hundred day simple moving average of $6.90. Aveanna Healthcare has a 12 month low of $3.67 and a 12 month high of $10.32. The company has a debt-to-equity ratio of 140.39, a current ratio of 1.23 and a quick ratio of 1.23.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings data on Monday, May 22nd. The company reported $0.04 EPS for the quarter. Aveanna Healthcare had a negative return on equity of 143.55% and a net margin of 3.29%.The firm had revenue of $450.53 million for the quarter. As a group, analysts predict that Aveanna Healthcare will post -0.06 EPS for the current fiscal year.

Insider Activity at Aveanna Healthcare

In other Aveanna Healthcare news, major shareholder Robert M. Williams, Jr. sold 10,000,000 shares of the firm’s stock in a transaction dated Tuesday, October 21st. The stock was sold at an average price of $9.00, for a total transaction of $90,000,000.00. Following the transaction, the insider owned 386,284 shares of the company’s stock, valued at approximately $3,476,556. This trade represents a 96.28% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, major shareholder J.H. Whitney Equity Partners V sold 8,346,059 shares of the business’s stock in a transaction dated Tuesday, October 21st. The shares were sold at an average price of $9.00, for a total value of $75,114,531.00. Following the completion of the sale, the insider directly owned 20,544,696 shares of the company’s stock, valued at $184,902,264. The trade was a 28.89% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 32,597,968 shares of company stock valued at $293,381,712 over the last three months. 7.80% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. Caxton Associates LLP acquired a new stake in Aveanna Healthcare during the 3rd quarter worth approximately $488,000. PharVision Advisers LLC increased its holdings in shares of Aveanna Healthcare by 37.6% in the third quarter. PharVision Advisers LLC now owns 20,595 shares of the company’s stock valued at $183,000 after purchasing an additional 5,630 shares during the period. XTX Topco Ltd purchased a new stake in shares of Aveanna Healthcare during the third quarter worth approximately $531,000. Voleon Capital Management LP acquired a new stake in shares of Aveanna Healthcare during the third quarter worth $2,949,000. Finally, Qube Research & Technologies Ltd grew its position in Aveanna Healthcare by 2.5% in the 3rd quarter. Qube Research & Technologies Ltd now owns 448,693 shares of the company’s stock valued at $3,980,000 after buying an additional 10,855 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.